Last reviewed: June 12, 2026
Last updated: June 12, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
GLP-1 receptor agonists like semaglutide have shown 15–22% weight loss in clinical trials, but dosing strategy matters as much as the medication itself. Your starting dose is deliberately low—often 0.25 mg weekly—then increases gradually over weeks or months based on your individual response and tolerance. Understanding how GLP-1 dosing works helps you achieve results safely without unexpected costs.
Why GLP-1 Dosing Starts Low and Increases Gradually
GLP-1 medications mimic a hormone that signals fullness to your brain and slows stomach emptying. Starting at a low dose allows your body to adapt to these changes, reducing nausea and other gastrointestinal side effects. Research shows that patients who begin at minimum doses and titrate upward report better tolerability and higher medication adherence than those starting at higher doses immediately.
Your prescriber increases your dose every 1–2 weeks based on how you respond. This titration phase typically lasts 4–8 weeks before reaching a maintenance dose where you experience steady appetite suppression and weight loss. Rushing through dose escalation or skipping steps increases the risk of severe nausea, vomiting, and constipation—side effects that can lead some patients to discontinue treatment entirely.
PlexusDx works with licensed 503A compounding pharmacies to ensure precise dosing at every step. Your dose may need to go up. Your price won't. All semaglutide injections from PlexusDx start at $149 per month, regardless of whether you're taking 0.25 mg or your final maintenance dose.
Standard GLP-1 Dosing Schedules for Semaglutide
The most common semaglutide dosing pattern mirrors FDA-approved clinical protocols. Week 1–4: 0.25 mg once weekly. Week 5–8: 0.5 mg once weekly. Week 9–12: 1.0 mg once weekly. Week 13+: 2.4 mg once weekly (maximum therapeutic dose). Some patients reach steady weight loss results at 1.0 mg or 1.4 mg and choose to maintain that dose rather than escalate further, which is a valid decision made with your provider.
Dose escalation may slow or pause if you experience moderate to severe side effects. Your prescriber might keep you at 0.5 mg for 6–8 weeks instead of advancing to 1.0 mg, allowing adaptation time. This individualized approach respects your body's tolerance while keeping you on track toward your weight loss goal. Starting with PlexusDx Microdose GLP-1 Protocol ($129/mo) is another option for patients who want to begin even more gradually or who have prior sensitivity to medications.
How Your Body Weight and Medical History Influence Dosing
Starting dose and titration speed depend partly on your baseline weight, age, kidney function, and diabetes status. Patients with type 2 diabetes may tolerate dose escalation differently than those without diabetes. Those with a history of pancreatitis, gallbladder disease, or certain cancers require closer monitoring and may follow a modified dosing schedule. Your medical history shapes your personalized protocol.
PlexusDx Precision Peptide Genetic Test identifies variants in your GLP1R gene (rs6923761), GIPR gene (rs1800437), and other metabolic pathways that influence how your body responds to GLP-1 therapy. Testing your genetic profile can help your prescriber predict whether you'll respond best at a standard dose, whether you need slower titration, or whether a combination therapy like GLP-Squared (semaglutide plus tirzepatide) may work better for you. The test costs $99 as an add-on after your first month of treatment and maps 14 peptide pathways and 49 distinct peptides.
Patients with severe kidney disease (eGFR <15 mL/min/1.73m²) need specialist oversight and may use lower maximum doses. Your PlexusDx provider reviews your lab results and medical summary before recommending your starting dose and escalation timeline.
Maintenance Dose and Long-Term Weight Loss Results
Once you reach your target dose—often 2.4 mg weekly for semaglutide—weight loss typically plateaus at 15–22% of baseline body weight over 48–68 weeks of treatment. Most patients maintain this dose indefinitely to sustain results. If weight loss stalls or reverses after several months at maintenance, your provider may adjust timing, add a complementary agent like tirzepatide (GLP-Squared Injection, $249/mo), or explore whether the Precision Peptide Genetic Test reveals unexpected genetic factors.
Stopping GLP-1 medication usually leads to weight regain within months, as appetite and metabolic rate return to baseline. Successful long-term weight loss with GLP-1 therapy often requires ongoing treatment paired with sustainable lifestyle changes. PlexusDx patients benefit from flat monthly pricing that makes long-term adherence financially predictable—your dose may increase, but your PlexusDx price stays the same.
Side Effects, Dose Tolerance, and When to Pause Escalation
Mild nausea, constipation, and reduced appetite are expected during dose escalation and usually fade within days to weeks. However, severe vomiting, abdominal pain, or signs of dehydration warrant immediate contact with your provider. Dose escalation can be paused, reversed, or slowed in response to side effects without compromising your long-term weight loss potential.
Staying well-hydrated, eating small protein-rich meals, and taking over-the-counter anti-nausea strategies (ginger, peppermint) help many patients tolerate dose increases better. Some prescribers recommend taking your semaglutide injection on an evening when you plan a light schedule the next day, allowing you to rest through the most intense side effects. If nausea persists beyond 1–2 weeks at a new dose, inform your PlexusDx provider—they can adjust your timeline or suggest an alternative compound like oral semaglutide.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Do I have to follow the standard 4-week dose escalation schedule, or can I go slower?
Absolutely—you can titrate more slowly. Some PlexusDx patients spend 6–8 weeks at each dose step to improve tolerance. Your prescriber customizes your timeline based on your side effects and comfort level. Slower escalation doesn't reduce your final weight loss; it just extends the dosing phase and may improve adherence.
What clinical evidence supports the 2.4 mg weekly maintenance dose?
The STEP clinical trials (published 2021–2023) demonstrated that 2.4 mg weekly semaglutide produced 15–22% weight loss in adults with obesity. However, doses of 1.0 mg and 1.4 mg also showed significant efficacy (9–15% loss), meaning maintenance at a lower dose is valid if you achieve your goal or experience limiting side effects.
How much does it cost if my dose increases with PlexusDx?
PlexusDx Semaglutide Injection starts at $149 per month and remains $149 per month whether you're at 0.25 mg or 2.4 mg. Your dose may need to go up. Your price won't. No membership fees, no insurance required, and HSA/FSA eligible.
Is it normal to feel nauseous when my dose increases, and when should I call my provider?
Mild nausea for 1–3 days after a dose increase is typical and usually improves with hydration and light meals. Contact your provider if nausea is severe, lasts beyond 1–2 weeks, or is accompanied by vomiting or abdominal pain. These symptoms may signal a need to pause escalation or switch delivery methods (oral vs. injection).
Can the Precision Peptide Genetic Test predict whether I'll need a higher or lower dose?
Yes. The test analyzes your GLP1R gene (rs6923761) and GIPR gene (rs1800437) variants, which influence how strongly you respond to GLP-1 medication. Results help your PlexusDx provider predict whether a standard dose, lower dose, or dual-therapy approach (GLP-Squared) may work best for your genetic profile. The test costs $99 after your first treatment month.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Can You Take Tirzepatide While Breastfeeding? What You Need to Know
Can You Get Ozempic Online? What You Need to Know About Safe Access and Weight Loss Support